Uploaded September 2026 | Updated November 2026, 16 hours ago
As AI reshapes the pace and precision of gene editing, the boundary between static treatments and adaptive, programmable medicines is beginning to blur. This panel explores the science, the ethics, and the stakes: from reversible approaches like RNA and the epigenome, to who decides where enhancement begins, to whether startups can make these technologies accessible and affordable at global scale.
The tools to engineer life have arrived: AI-driven biological design, synthetic DNA at scale, precision epigenomics, and cloud laboratories. Biology is becoming programmable, creating a new foundation for research, engineering, and healthcare where one patient, one genome, or one startup can change everything.
๐ Subscribe for more deep tech insights!
๐ฒ Follow us on social media:
LinkedIn: hello-tomorrow-challenge
Instagram: hellotomorrow_official
#deeptech #geneediting #innovation #hellotomorrow
As AI reshapes the pace and precision of gene editing, the boundary between static treatments and adaptive, programmable medicines is beginning to blur. This panel explores the science, the ethics, and the stakes: from reversible approaches like RNA and the epigenome, to who decides where enhancement begins, to whether startups can make these technologies accessible and affordable at global scale.
The tools to engineer life have arrived: AI-driven biological design, synthetic DNA at scale, precision epigenomics, and cloud laboratories. Biology is becoming programmable, creating a new foundation for research, engineering, and healthcare where one patient, one genome, or one startup can change everything.
๐ Subscribe for more deep tech insights!
๐ฒ Follow us on social media:
LinkedIn: hello-tomorrow-challenge
Instagram: hellotomorrow_official
#deeptech #geneediting #innovation #hellotomorrow










